evidence of pure yolk sac (endodermal sinus) tumours all had raised levels. Teratomas containing yolk sac elements may or may not be associated with raised serum levels. Trophoblastic (choriocarcinomatous) elements in a teratoma were not normally associated with high values. Fourteen patients with teratomas had elevated levels in the absence of histologically detectable yolk sac elements. Serum AFP levels often became elevated before clinical evidence of recurrence, so that AFP can act as an effective marker of the course of the disease and its response to therapy in many patients, but recurrent or progressive disease may be present in the absence of raised levels.
ax-Foetoprotein (AFP), one of the main serum proteins of early human and other mammalian foetuses (Abelev, 1968; Gitlin, 1974) , is produced mainly by the embryonic yolk sac and foetal liver (Gitlin, Perricelli and Gitlin, 1972) . Serum levels decline shortly after birth, and remain low throughout adult life (Masseyeff et al., 1974) . However, raised levels have been detected in the amniotic fluid in association with open neural tube defects (Adinolfi, Adinolfi and Lessof, 1975) , in the serum during pregnancy, and in some patients with primary hepatocellular carcinomas, germ cell tumours, metastatic tumours of the liver, and non-neoplastic liver disease (Laurence and Neville, 1972; Silver et al., 1974) . Tumours of other endodermally derived organs may, in rare instances, be associated with elevated levels (Akai and Kato, 1973; McIntire et al., 1975) , although in such patients plasma carcinoembryonic antigen (CEA) is a more reliable tumour index (Grigor et al., 1975) .
Raised serum AFP levels may occur in association with testicular tumours containing teratomatous elements, but not with seminomas or choriocarcinomas (Abelev, 1968 (Abelev, , 1974 and teratomas with raised levels are said to carry a poorer prognosis (N0rgaard-Pedersen, . The reasons for this are unclear, but could be due to the presence of a specific population of cells in such teratomas. Yolk sac tumours in man and animals have been shown to contain or produce AFP (Ballas, 1972; Engelhardt, Poltoranina and Yazova, 1973; Hooghe and Zeicher, 1974; N0rgaard-Pederson, 1974, 1975) , and isolated reports of high serum AFP levels with testicular tumours containing yolk sac (endodermal sinus) elements or polyembryoma have appeared (Abelev, 1974; Bourgeaux et al., 1971; Tsuchida et al., 1973; Teilum et al., 1974 Teilum et al., , 1975 .
The purposes of this paper were to review a large series of patients with malignant testicular and germ cell tumours, and ascertain the clinical role of serum AFP assays, and their relationship to a comprehensive histopathological classification of these tumours.
MATERIALS AND METHODS
Patients.-The 153 patients of this study were referred to the Royal Marsden Hospital (RMH) Surrey and London for treatment of malignant germ cell tumours initially diagnosed at other hospitals. All but 4 of these patients had primary testicular tumours: one patient had a primary mediastinal seminoma, one had an abdominal yolk sac tumour, one had widespread teratoma with unknown site of origin, and one had a primary retroperitoneal teratoma. The age at diagnosis ranged from 4 months to 79 years, with the peak incidence in the third and fourth decades (Fig. 1 (Teilum, 1959) or yolk sac tumours as defined by Teilum (1971 Teilum ( , 1976 were classified as yolk sac evidence of hepatic and malignant disease, had AFP levels between 2 and 16 ng/ml (mean 4-6 : 2-6 ng/ml). Values in excess of 25 ng/ml were considered in this study to be elevated, and values between 16 and 25 ng/ml were equivocal but not definitely raised.
RESULTS
Serum AFP levels as a function of type and activity of the tumour The incidence of raised serum AFP levels as a function of the different histological types of tumour, and whether disease is active or non-active, is illustrated in Table I . No patient with a pure seminoma gave a raised value: of those with active teratomas, alone or in combination with a seminoma, 56/84 (67%o)
were associated with high serum AFP levels, ranging from 28 to 88,000 ng/ml. Four patients with teratomas had a raised level in the first postoperative sample only: normal values were detected thereafter, and no residual or recurrent disease was discovered after a follow-up period of between 12 and 21 months, indicating that an elevated result shortly after surgery does not necessarily signify the presence of residual disease, but suggests that preoperative values were high and had not had time to fall into the normal range. An elevated serum AFP persisted for up to 5 weeks in one patient.
Histological sub-types and AFP serum levels After extensive histological assessment, 29 of the 84 active teratomas were found which could be classified as belonging to a single histological sub-type (Table II) . It may be seen that in our series, pure yolk sac tumours were always associated with raised levels, while trophoblastic tumours Adjuvant chemotherapy and radiotherapy in addition to surgical removal of tumour usually resulted in a fall in AFP levels (Figs. 3 and 4) , but this was not always accompanied by clinical regression of the disease. Twenty-two patients had falling AFP levels over a period when therapy caused a reduction in tumour 1 -F. patients had evidence of progressive *disease at a time when serum AFP was falling, and at least 11 of these patients had normal AFP levels at death (Fig. 4) Teilum et al., 1974 Teilum et al., , 1975 (1973a) have also demonstrated HCG-,/ in many non-trophoblastic tumours. By analogy, there is no reason to conclude that AFPproducing testicular teratomas always contain yolk sac elements, and if we regard AFP and inappropriate hormones as being similar, it must be remembered that morphological and functional differentiation need not always be associated.
Serum AFP measurements have a valuable role to play in the follow-up of patients with germ cell tumours. If postoperative values fail to return to normal after approximately one month, residual tumour is present. Once a patient is in complete clinical remission, a recurrence is often preceded by a rise in AFP levels, as we have shown in 9 patients with a mean lead time of 15 weeks. However, tumour recurrence may be apparent clinically before serum levels rise, or serum AFP may increase simultaneously with clinical evidence of metastatic disease. Tumours which are originally AFPproducing may recur without an associated elevation in serum levels, but tumours which initially show no evidence of AFP secretion may be accompanied by high serum levels when recurrence supervenes. In our series, a confirmed elevated serum level of AFP always indicated the presence of active teratoma, and rising AFP levels only occurred in patients with progressive disease, whereas a falling AFP level may indicate a good response to therapy but may also accompany progressive disease, and a normal serum AFP can occur in patients with active tumour. Braunstein et al. (1973b) and Perlin et al. (1976) have shown that simultaneous monitoring of serum AFP and HCG-,/ gives a more reliable indication of tumour activity than the measurement of either alone. In many cases, the levels of these 2 markers fluctuate independently of each other, as if different cells were responsible for their production, and had different responsiveness to chemotherapy.
